Dan Malleck: Habitual risk: Insurance, professional authority and the medicalization of addiction in the 19th century

Can't see the video?

You need to upgrade your Flash Player to version 8 or newer.
Click HERE to get it.

Under Control?
Under Control?
Location: London School of Hygiene and Tropical Medicine
View Contributor Video List >>
Events And Seminars
In his influential textbooks on medical jurisprudence, Alfred Swaine Taylor observed that the opium habit, while generally a personal vice, was viewed by the emerging life insurance/assurance industry as a risky behaviour that might preclude an individual obtaining life insurance coverage. Taylor and others, such as the equally influential Robert Christison, debated in the pages of their books, the truth of this statement: whether opium habit limited life spans, and should be considered by the medical profession as something more than a personal problem, however iatrogenic it may be. When examining the medicalization of addiction, historians have tended to look to two sources for epistemological
roots: medical science and the law. Yet neither of these forms of knowledge is removed from other social, political and economic influences. Like many professionals establishing both their authority and their financial viability, physicians were drawn to the insurance industry as a source of investment to secure their financial future. They were also wooed by the industry, since a medical doctor’s certificate was useful, and eventually required, to guarantee that the
applicant for insurance was healthy enough that insuring them did not pose an undue risk to the company and its investors. By the end of the century, many insurance companies were hiring physicians to manage corporate divisions dedicated to assessing risk, physician groups were setting prices for the medical exam (paid for by the insurance company) and medical literature on a range of illnesses often included commentary on how that illness might affect
the patient’s ability to obtain insurance. This paper looks at how the symbiotic but often fraught relationship between physicians and insurance companies affected the idea of habit as a medical condition. It uses the example of Canadian medical literature, highly influenced by both British and American developments in medical science and medical professionalization, to explore the intricacies of this relationship and whether and how life insurance affected
medical ideas. It posits that historians need to pay attention to the influence of private industry which, even if not directly involved in the practice of medicine (such as the pharmaceutical industry), may have had considerable impact on the development of a disease theory of addiction.
View related videos
There are currently no footnotes for this video.
News and articles library
World Drug Report 2014 >>

3rd July 14 -  Drug use prevalence is stable around the world, according to the 2014 World Drug Report of the United Nations Office on Drugs and Crime (UNODC), with around 243 million individuals, or 5 per cent of the world’s population aged 15-64, having used an illicit drug in 2012. Problem drug users meanwhile numbered about 27 million, roughly 0.6 per cent of the world’s adult population, or 1 in every 200 people.
The impact of the older generation on England’s healthcare system >>

26th June 14 - The government has produced a report looking at the impact people aged over 65 have on the NHS. This publication provides a compilation of information on older people living in England to give a broad picture of their health, care and wellbeing.
The Condition of Britain: Strategies for Social Renewal >>

19th June 14 - This report by the Institute for Public Policy Research (IPPR), sets out a comprehensive new agenda for reforming the state and social policy to enable people in Britain to work together to build a stronger society in tough times.
European Drug Report 2014 >>

28th May 14 - The EMCDDA presents its annual overview of the European drug situation on 27 May in a multilingual, multimedia information package focusing on today’s rapidly shifting drug phenomenon.
Related Videos